[go: up one dir, main page]

WO2001076507A3 - Use of oxygen carriers to improve grafted cell survival in neural transplantation - Google Patents

Use of oxygen carriers to improve grafted cell survival in neural transplantation Download PDF

Info

Publication number
WO2001076507A3
WO2001076507A3 PCT/US2001/011564 US0111564W WO0176507A3 WO 2001076507 A3 WO2001076507 A3 WO 2001076507A3 US 0111564 W US0111564 W US 0111564W WO 0176507 A3 WO0176507 A3 WO 0176507A3
Authority
WO
WIPO (PCT)
Prior art keywords
cell survival
oxygen carriers
neural transplantation
grafted cell
improve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/011564
Other languages
French (fr)
Other versions
WO2001076507A2 (en
Inventor
Jacqueline Sagen
Elizabeth Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miami
Original Assignee
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miami filed Critical University of Miami
Publication of WO2001076507A2 publication Critical patent/WO2001076507A2/en
Publication of WO2001076507A3 publication Critical patent/WO2001076507A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

A stem cell transplantation medium containing a serum-free physiologically suitable aqueous carrier; about 1 % to about 20 % of an oxygen carrier; and optionally one or more growth factors or differentiation factors is disclosed. Also disclosed is the use of an oxygen carrier in a stem cell transplantation medium.
PCT/US2001/011564 2000-04-11 2001-04-11 Use of oxygen carriers to improve grafted cell survival in neural transplantation Ceased WO2001076507A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19609400P 2000-04-11 2000-04-11
US60/196,094 2000-04-11

Publications (2)

Publication Number Publication Date
WO2001076507A2 WO2001076507A2 (en) 2001-10-18
WO2001076507A3 true WO2001076507A3 (en) 2002-07-04

Family

ID=22724083

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/011564 Ceased WO2001076507A2 (en) 2000-04-11 2001-04-11 Use of oxygen carriers to improve grafted cell survival in neural transplantation

Country Status (1)

Country Link
WO (1) WO2001076507A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL147412A0 (en) * 2001-12-31 2002-08-14 Yeda Res & Dev The use of il6r/il6 chimera in nerve cell regeneration
JP2008526891A (en) * 2005-01-11 2008-07-24 コグネート セラピューティクス，インコーポレーテッド Bone marrow stromal cells for immune defense of transplanted neural stem cells
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20090197823A1 (en) 2006-05-09 2009-08-06 Braincells, Inc. Aliskiren modulation of neurogenesis
JP2009536669A (en) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド Neurogenesis by angiotensin regulation
US9381273B2 (en) 2008-01-31 2016-07-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Scaffolds with oxygen carriers, and their use in tissue regeneration
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US9790468B2 (en) 2013-03-15 2017-10-17 Avita Iinternational Ltd. Multifunctional immature dental pulp stem cells and therapeutic applications

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1146759A (en) * 1997-08-06 1999-02-23 Terumo Corp Cell culture fluid
WO2000005343A2 (en) * 1998-07-24 2000-02-03 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Cell expansion system for use in neural transplantation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895810A (en) 1995-03-23 1999-04-20 Biopure Corporation Stable polymerized hemoglobin and use thereof
US6150507A (en) 1995-03-23 2000-11-21 Biopure Corporation Method for producing a purified hemoglobin product
US5952470A (en) 1995-06-07 1999-09-14 Biopure Corporation Method for separating unmodified hemoglobin from cross-linked hemoglobin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1146759A (en) * 1997-08-06 1999-02-23 Terumo Corp Cell culture fluid
WO2000005343A2 (en) * 1998-07-24 2000-02-03 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Cell expansion system for use in neural transplantation

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2001, POTTER E D ET AL: "Cytokine-treated mesencephalic progenitor nigral grafts in a Parkinson's Disease model.", XP002182960, Database accession no. PREV200100498298 *
DATABASE WPI Section Ch Week 199918, Derwent World Patents Index; Class B04, AN 1999-208102, XP002182961 *
POTTER E D ET AL: "Effects of ultrapurified hemoglobin on survival of mesencephalic progenitor cells in striatal grafts.", EXPERIMENTAL NEUROLOGY, vol. 164, no. 2, August 2000 (2000-08-01), Seventh Annual Conference of the American Society for Neural Transplantation and Repair;Clearwater, Florida, USA; April 27-30, 2000, pages 445, XP001031488, ISSN: 0014-4886 *
POTTER ELIZABETH D ET AL: "Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons.", CELL & TISSUE RESEARCH, vol. 296, no. 2, May 1999 (1999-05-01), pages 235 - 246, XP002182959, ISSN: 0302-766X *
SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 27, no. 1, 2001, 31st Annual Meeting of the Society for Neuroscience;San Diego, California, USA; November 10-15, 2001, pages 936, ISSN: 0190-5295 *
WASCHKE K F ET AL: "Biomedical applications of artificial oxygen carriers.", INFUSIONSTHERAPIE UND TRANSFUSIONMEDIZIN., vol. 26, no. Suppl. 2, November 1999 (1999-11-01), pages 31 - 36, XP001031476, ISSN: 1019-8466 *

Also Published As

Publication number Publication date
WO2001076507A2 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
CA2148138A1 (en) Biological factors and neural stem cells
AU8128094A (en) (in vitro) amplification of stem cells
EP1077072B8 (en) In vitro process for the preparation of heart valve or vessel prothese
EP2457999A3 (en) Culture medium for pluropotent stem cells
BR0108507A (en) Serum-free culture of primate embryonic stem cells
CA2116221A1 (en) Animal cell culture
AU7213294A (en) Methods of culturing and modulating the growth of hair follicular stem cells
AU1002497A (en) Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
CA2390281A1 (en) Hematopoietic differentiation of human embryonic stem cells
IL192762A0 (en) Method for identifying cell differentiation factors
EP1398370A3 (en) In-vitro micro-organs
AU4221399A (en) Human cd45+ and/or fibroblast + mesenchymal stem cells
WO2001076507A3 (en) Use of oxygen carriers to improve grafted cell survival in neural transplantation
FR15C0055I1 (en)
WO1994010203A3 (en) Op-3-induced morphogenesis
CA2146734A1 (en) Method for long term subculture of dermal papilla cells
CA2058930A1 (en) Media for cell growth and method for making them
AU1478000A (en) (in utero) transplantation of human mesenchymal stem cells
CA2230159A1 (en) Use of aminoadamantane compounds as immunoregulators
CA2328423A1 (en) Amino acid modified polypeptides
AU2197897A (en) Use of delta-like protein to inhibit the differentiation of stem cells
CA2250880A1 (en) Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
CA2335171A1 (en) Method for producing high concentration carbon dioxide product
WO1998036636A3 (en) Method for generating embryogenic cell cultures for the production of bananas (musa spp.)
AU4299696A (en) Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP